Patent · US Active

Modified polynucleotides for the production of nuclear proteins

US9283287B2 · kind B2 · utility

76Cited by

399References

24Claims

0Family size

Assignee

Moderna Therapeutics, Inc. · US

Inventors

Tirtha Chakraborty · Medford, US
Antonin de Fougerolles · Waterloo, BE
Ron Weiss · Newton, US

Key dates

Filing date	Apr 23, 2015
Grant date	Mar 15, 2016
Priority date	—
Expiry date	Apr 23, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2840/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to compositions and methods for the preparation, manufacture and therapeutic use of polynucleotides, primary transcripts and mmRNA molecules.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.